Urticaria

被引:19
作者
Amar, Sheila M. [1 ,2 ]
Dreskin, Stephen C. [1 ,3 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Allergy & Clin Immunol, Denver, CO 80262 USA
[2] Univ Colorado, Natl Jewish Med & Res Ctr, Div Allergy & Immunol, Denver, CO 80206 USA
[3] Univ Colorado Hosp, Aurora, CO 80045 USA
来源
PRIMARY CARE | 2008年 / 35卷 / 01期
关键词
D O I
10.1016/j.pop.2007.09.009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Urticaria with or without angioedema is frequently encountered in primary care medicine. Although many patients and physicians think that urticaria is evidence of an IgE-mediated allergic reaction, often the etiology of urticaria is unknown. This uncertainty frequently results in patients enduring unnecessary lifestyle changes or extensive testing. In more persistent cases, patients achieve control of their disease only with the use of more toxic medications, such as corticosteroids, and this can lead to a range of systemic complications. Acute urticaria is typically due to a hypersensitivity reaction while chronic urticaria has a more complex pathogenesis. Antihistamines remain the mainstay of symptomatic treatment for both.
引用
收藏
页码:141 / +
页数:19
相关论文
共 61 条
[1]   The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results [J].
Bagenstose, SE ;
Levin, L ;
Bernstein, JA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (01) :134-140
[2]   EFFICACY AND SAFETY OF ASTEMIZOLE, A LONG-ACTING AND NONSEDATING H-1 ANTAGONIST FOR THE TREATMENT OF CHRONIC IDIOPATHIC URTICARIA [J].
BERNSTEIN, IL ;
BERNSTEIN, DI .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 77 (01) :37-42
[3]   Urticaria pigmentosa [J].
Brockow, K .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (02) :287-+
[4]   EFFECTS OF H-1-ANTIHISTAMINE DRUG REGIMEN ON HISTAMINE-RELEASE BY NONLESIONAL SKIN MAST-CELLS OF PATIENTS WITH CHRONIC URTICARIA [J].
BRUNET, C ;
BEDARD, PM ;
HEBERT, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 86 (05) :787-793
[5]   Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome [J].
Davis, MDP ;
Brewer, JD .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (02) :183-+
[6]   EVALUATION OF A PATIENT WITH BOTH AQUAGENIC AND CHOLINERGIC URTICARIA [J].
DAVIS, RS ;
REMIGIO, LK ;
SCHOCKET, AL ;
BOCK, SA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1981, 68 (06) :479-483
[7]   Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria [J].
Di Lorenzo, G ;
Pacor, ML ;
Mansueto, P ;
Pellitteri, ME ;
Lo Bianco, C ;
Ditta, V ;
Martinelli, N ;
Rini, GB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) :619-625
[8]   Urticaria: Selected highlights and recent advances [J].
Dibbern, DA .
MEDICAL CLINICS OF NORTH AMERICA, 2006, 90 (01) :187-+
[9]   Urticaria and angioedema: an overview [J].
Dibbern, DA ;
Dreskin, SC .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (02) :141-+
[10]   Physical urticaria [J].
Dice, JP .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (02) :225-+